Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2
- PMID:10847592
- DOI: 10.1210/mend.14.6.0471
Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2
Abstract
ASC-2 was recently discovered as a cancer-amplified transcription coactivator molecule of nuclear receptors, which interacts with multifunctional transcription integrators steroid receptor coactivator-1 (SRC-1) and CREB-binding protein (CBP)/p300. Herein, we report the identification of three mitogenic transcription factors as novel target molecules of ASC-2. First, the C-terminal transactivation domain of serum response factor (SRF) was identified among a series of ASC-2-interacting proteins from the yeast two-hybrid screening. Second, ASC-2 specifically interacted with the activating protein-1 (AP-1) components c-Jun and c-Fos as well as the nuclear factor-kappaB (NFkappaB) components p50 and p65, as demonstrated by the glutathione S-transferase pull-down assays as well as the yeast two-hybrid tests. In cotransfection of mammalian cells, ASC-2 potentiated transactivations by SRF, AP-1, and NFkappaB in a dose-dependent manner, either alone or in conjunction with SRC-1 and p300. In addition, ASC-2 efficiently relieved the previously described transrepression between nuclear receptors and either AP-1 or NFkappaB. Overall, these results suggest that the nuclear receptor coactivator ASC-2 also mediates transactivations by SRF, AP-1, and NFkappaB, which may contribute to the putative, ASC-2-mediated tumorigenesis.
Similar articles
- Two distinct nuclear receptor-interaction domains and CREB-binding protein-dependent transactivation function of activating signal cointegrator-2.Lee SK, Jung SY, Kim YS, Na SY, Lee YC, Lee JW.Lee SK, et al.Mol Endocrinol. 2001 Feb;15(2):241-54. doi: 10.1210/mend.15.2.0595.Mol Endocrinol. 2001.PMID:11158331
- Hepatitis B virus X protein regulates transactivation activity and protein stability of the cancer-amplified transcription coactivator ASC-2.Kong HJ, Park MJ, Hong S, Yu HJ, Lee YC, Choi YH, Cheong J.Kong HJ, et al.Hepatology. 2003 Nov;38(5):1258-66. doi: 10.1053/jhep.2003.50451.Hepatology. 2003.PMID:14578865
- Interaction and functional cooperation of the cancer-amplified transcriptional coactivator activating signal cointegrator-2 and E2F-1 in cell proliferation.Kong HJ, Yu HJ, Hong S, Park MJ, Choi YH, An WG, Lee JW, Cheong J.Kong HJ, et al.Mol Cancer Res. 2003 Nov;1(13):948-58.Mol Cancer Res. 2003.PMID:14638867
- Nuclear hormone receptor coregulator: role in hormone action, metabolism, growth, and development.Mahajan MA, Samuels HH.Mahajan MA, et al.Endocr Rev. 2005 Jun;26(4):583-97. doi: 10.1210/er.2004-0012. Epub 2004 Nov 23.Endocr Rev. 2005.PMID:15561801Review.
- Nuclear receptor coactivator/coregulator NCoA6(NRC) is a pleiotropic coregulator involved in transcription, cell survival, growth and development.Mahajan MA, Samuels HH.Mahajan MA, et al.Nucl Recept Signal. 2008 Feb 1;6:e002. doi: 10.1621/nrs.06002.Nucl Recept Signal. 2008.PMID:18301782Free PMC article.Review.
Cited by
- Activating signal cointegrator 2 belongs to a novel steady-state complex that contains a subset of trithorax group proteins.Goo YH, Sohn YC, Kim DH, Kim SW, Kang MJ, Jung DJ, Kwak E, Barlev NA, Berger SL, Chow VT, Roeder RG, Azorsa DO, Meltzer PS, Suh PG, Song EJ, Lee KJ, Lee YC, Lee JW.Goo YH, et al.Mol Cell Biol. 2003 Jan;23(1):140-9. doi: 10.1128/MCB.23.1.140-149.2003.Mol Cell Biol. 2003.PMID:12482968Free PMC article.
- PRIP promotes tumor formation through enhancing serum-responsive factor-mediated FOS expression.Zhu YT, Hu L, Qi C, Zhu YJ.Zhu YT, et al.J Biol Chem. 2009 May 22;284(21):14485-92. doi: 10.1074/jbc.M900935200. Epub 2009 Mar 26.J Biol Chem. 2009.PMID:19329434Free PMC article.
- CAPERalpha is a novel Rel-TAD-interacting factor that inhibits lymphocyte transformation by the potent Rel/NF-kappaB oncoprotein v-Rel.Dutta J, Fan G, Gélinas C.Dutta J, et al.J Virol. 2008 Nov;82(21):10792-802. doi: 10.1128/JVI.00903-08. Epub 2008 Aug 27.J Virol. 2008.PMID:18753212Free PMC article.
- The roles of sex steroid receptor coregulators in cancer.Gao X, Loggie BW, Nawaz Z.Gao X, et al.Mol Cancer. 2002 Nov 14;1:7. doi: 10.1186/1476-4598-1-7.Mol Cancer. 2002.PMID:12473178Free PMC article.Review.
- Coactivators in PPAR-Regulated Gene Expression.Viswakarma N, Jia Y, Bai L, Vluggens A, Borensztajn J, Xu J, Reddy JK.Viswakarma N, et al.PPAR Res. 2010;2010:250126. doi: 10.1155/2010/250126. Epub 2010 Aug 5.PPAR Res. 2010.PMID:20814439Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous